Pictet Asset Management (Switzerland)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$79.3M Sell
617,456
-16,459
-3% -$1.99M 0.09% 222
2023
Q1
$73.6M Buy
633,915
+3,400
+0.5% +$381K 0.09% 235
2022
Q4
$71.4M Sell
630,515
-8,527
-1% -$936K 0.1% 223
2022
Q3
$51.5M Buy
639,042
+60,153
+10% +$5.09M 0.08% 261
2022
Q2
$43.1M Sell
578,889
-75,675
-12% -$6.91M 0.06% 308
2022
Q1
$83.7M Sell
654,564
-57,748
-8% -$6.32M 0.09% 240
2021
Q4
$95.6M Sell
712,312
-8,540
-1% -$1.23M 0.1% 237
2021
Q3
$98.6M Buy
+720,852
New +$90.9M 0.11% 228

Other funds holding DXCM

Pictet Asset Management (Switzerland)'s DXCM Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its DexCom (DXCM) stake by 2.6% in Q2 2023, selling an estimated $1.99M and leaving 617,456 shares worth $79.3M. The position accounts for 0.09% of the portfolio, ranked #222.

Pictet Asset Management (Switzerland) first reported a position in DXCM in Q3 2021 and has held it in 8 quarters since. The position peaked at $98.6M in Q3 2021. 955 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 617,456 shares of DexCom worth $79.3M as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 16,459 DexCom shares in Q2 2023, an estimated $1.99M.
  • DexCom made up 0.09% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #222 holding.
  • Pictet Asset Management (Switzerland) first reported a position in DexCom in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s DexCom position peaked at $98.6M in Q3 2021.
  • 955 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.